Acceleron Pharma, a biopharmaceutical company, has appointed Kevin McLaughlin as senior vice president (SVP) and chief financial officer (CFO). McLaughlin has more than 30 years of financial and operating management experience spanning the biotech, high tech and education industries.
Most recently, he served as SVP and CFO of Qteros, a cellulosic biofuels company. From 1996 through 2007, he held several executive positions with Praecis Pharmaceuticals. He joined the company as its CFO, where he had responsibility for private financings, partnership financings, the company’s initial public offering (IPO) and subsequent secondary stock offerings. Later, McLaughlin became chief operating officer (COO), and then president and chief executive officer (CEO), as well as serving as a member of the board of directors. In this capacity he was responsible for negotiating the sale of the company to GlaxoSmithKline (GSK).
He began his career in senior financial roles at Prime Computer and Computervision Corporation. McLaughlin received a BS from Northeastern University and MBA from Babson College.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more